Semintra

Authorised

This medicine is authorised for use in the European Union

telmisartan

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Semintra : EPAR - Summary for the public

Product information

Semintra : EPAR - Product Information

Semintra : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Semintra
• Active substance:
  telmisartan
• International non-proprietary name (INN) or common name:
  telmisartan

Pharmacotherapeutic group

• Agents acting on the renin-angiotensin system
• Angiotensin II antagonists, plain

Authorisation details

• EMA product number:
  EMEA/V/C/002436

Assessment history

Changes since initial authorisation of medicine

Semintra : EPAR - Procedural steps taken and scientific information after authorisation

Semintra-V-C-2436-X-0008 : EPAR - Assessment Report - Variation

CVMP post-authorisation summary of positive opinion for Semintra

Adopted Reference Number: EMA/CVMP/25787/2018

Initial marketing authorisation documents

Semintra : EPAR - Public assessment report

Adopted

CVMP summary of positive opinion for Semintra

Reference Number: EMA/CVMP/734548/2012